Aclarion, Inc. (ACON) 是一家上市公司 属于 医疗保健 板块，经营于 Medical - Healthcare Information Services 行业. 公司总部位于 Broomfield, CA, 美国. 现任CEO为 Brent Ness.
ACON 拥有 IPO日期为 2022-04-22, 5 名全职员工, 在 NASDAQ Capital Marke, 市值为 $1.74M.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
